mci 9038 has been researched along with Coronary Artery Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirohata, A; Kataoka, K; Kimura, T; Kozuma, K; Morino, Y; Tanabe, K; Tobaru, T; Yasuda, S | 1 |
| Hursting, MJ; Jang, IK | 1 |
| Hursting, MJ; Jang, IK; McCollum, D | 1 |
3 other study(ies) available for mci 9038 and Coronary Artery Disease
| Article | Year |
|---|---|
Biodegradable polymer-based, argatroban-eluting, cobalt-chromium stent (JF-04) for treatment of native coronary lesions: final results of the first-in-man study and lessons learned.
Topics: Absorbable Implants; Adult; Aged; Aged, 80 and over; Arginine; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pipecolic Acids; Sulfonamides; Treatment Outcome | 2016 |
Effect of body mass index on Argatroban therapy during percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Blood Coagulation; Body Mass Index; Coronary Artery Disease; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Obesity; Pipecolic Acids; Retrospective Studies; Sulfonamides; Thrombocytopenia | 2008 |
Argatroban therapy in patients with coronary artery disease and heparin-induced thrombocytopenia.
Topics: Aged; Amputation, Surgical; Anticoagulants; Arginine; Case-Control Studies; Cause of Death; Coronary Artery Disease; Female; Heparin; Humans; Male; Pipecolic Acids; Prospective Studies; Statistics, Nonparametric; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2008 |